Ucb Biopharma Srl
Clinical trials sponsored by Ucb Biopharma Srl, explained in plain language.
-
New inhaler aims to halt seizures in 90 seconds
Disease control Recruiting nowThis study tests an inhaled medication called Staccato alprazolam to see if it can stop a prolonged seizure within 90 seconds and prevent it from coming back for at least 2 hours. It is for people aged 12 and older who have predictable, long-lasting seizures. The trial compares t…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for painful hand and foot blisters: drug trial underway
Disease control Recruiting nowThis study tests a drug called bimekizumab against a placebo in 300 adults with palmoplantar pustulosis, a skin condition causing painful blisters on hands and feet. The goal is to see if the drug can clear or nearly clear the blisters by 16 weeks. Participants must have moderate…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for kids with arthritis? drug trial launches for young patients
Disease control Recruiting nowThis study tests a drug called bimekizumab in children aged 2 to 17 with active juvenile arthritis (enthesitis-related arthritis or juvenile psoriatic arthritis). The goal is to measure how the drug moves through the body and check for side effects. About 40 children will take pa…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 15, 2026 11:53 UTC